We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
US-based clinical-stage biotechnology company Novavax has called upon the expertise of Australian based Nucleus Network (Nucleus) to commence Phase 1 clinical trials for its COVID-19 vaccine trials.